Daito Pharmaceutical Co.,Ltd. - Laporan Arus Kas (TTM)

Daito Pharmaceutical Co.,Ltd.
US ˙ OTCPK ˙ JP3486150000

Laporan Arus Kas (TTM)

Laporan Arus Kas Daito Pharmaceutical Co.,Ltd. menunjukkan perubahan posisi kas dari waktu ke waktu. Data Laporan Arus Kas meliputi Kas dari Aktivitas Operasional (CFOP), Kas dari Aktivitas Investasi, dan Kas dari Aktivitas Pendanaan.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
11-30
2021
05-31
2021
11-30
2022
05-31
2022
11-30
2023
05-31
2023
11-30
2024
05-31
2024
11-30
2025
05-31
Cash From Operating Activities 3,455 5,182 5,870 4,370 3,104 4,155 4,960 5,182 5,076 5,897
Change (%) 49.99 13.28 -25.55 -28.97 33.86 19.37 4.48 -2.05 16.17
% of Cash Flow 678.78 1,799.31 931.75 433.53 150.53 -536.82 -382.42 -589.53 -377.96 -1,136.22
Cash From Investing Activities -4,011 -6,324 -5,362 -4,400 -4,669 -5,566 -7,637 -5,930 -7,601 -7,365
Change (%) 57.67 -15.21 -17.94 6.11 19.21 37.21 -22.35 28.18 -3.10
% of Cash Flow -788.02 -2,195.83 -851.11 -436.51 -226.43 719.12 588.82 674.63 565.97 1,419.08
Cash From Financing Activities 1,066 1,424 119 989 3,540 616 1,354 -183 1,172 1,002
Change (%) 33.58 -91.64 731.09 257.94 -82.60 119.81 -113.52 -740.44 -14.51
% of Cash Flow 209.43 494.44 18.89 98.12 171.68 -79.59 -104.39 20.82 -87.27 -193.06
Cash Flow 509 288 630 1,008 2,062 -774 -1,297 -879 -1,343 -519
Change (%) -43.42 118.75 60.00 104.56 -137.54 67.57 -32.23 52.79 -61.36
% of Cash Flow 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00

Source: Capital IQ

Other Listings
JP:4577 JP¥ 1,234.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista